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Background/Aims: Pyogenic liver abscess (PLA) is a seri-
ous, life threatening condition with a high mortality rate that 
represents a diagnostic and therapeutic challenge. The aim 
of this study was to collect demographic data and clinical, 
laboratory and microbiological characteristics of PLA patients 
treated between 2000 and 2010. We also aimed to collect 
information regarding our management experience of these 
cases. Methods: As a retrospective review, 47 patients with 
PLA in a tertiary referral center were examined to determine 
their demographic characteristics, clinical features, and 
laboratory, imaging, and microbiologic findings as well as 
the treatment outcome. Results: Cryptogenic PLA was the 
most frequently identified type of PLA, while benign biliary 
tract disease was the most frequently identiﬁ  able cause of 
PLA (18/47 patients; 38.3%). Leukocytosis and elevated 
alanine transaminase were common laboratory findings 
and were observed in 35 (74.5%) and 22 (46.8%) patients, 
respectively. Increased fibrinogen was also detected in 11 
of 15 investigated cases (73.3%). Notably, infection-induced 
thrombocytopenia occurred in 8 patients (17%). Diabetes 
mellitus was associated with the occurrence of infection 
induced shock when compared to the non-diabetic group 
(p<0.05). Patients with two or more comorbid diseases had 
longer hospitalizations when compared to patients with one 
comorbid disease or those without comorbidities (p<0.001). 
The number of days needed to establish diagnosis was cor-
related with the length of hospitalization (p<0.001). The 
overall hospital mortality rate was 2.1% (1/47). Conclusions: 
Characteristics of PLA patients from the past 10 years are 
presented. The number of days needed to establish a PLA 
diagnosis was correlated with the length of the hospital stay. 
The hospital stay of PLA patients can be further improved 
by early diagnosis and effective treatments during the early 
stages of PLA progression. (Gut Liver 2011;5:221-227)
Key Words: Asian Continental Ancestry Group;   Pyogenic liver 
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INTRODUCTION
Pyogenic liver abscess (PLA) is a serious, life threatening 
condition, with a mortality rate of 6% to 14%.
1-4 PLA remains 
a major diagnostic and therapeutic challenge, despite advances 
in diagnostic technology and new strategies for treatment. Its 
clinical incidence varies from region to region, but has been 
reported between 0.006% to 2.2% of the hospital admissions.
5,6 
The mortality rate for liver abscess has changed in the last de-
cades, because of improved imaging modalities, nutritional, and 
therapeutic support of critically ill patients.
3,4,7,8
The etiology and management of PLA has changed substan-
tially in the past few decades. Due to the advent of highly de-
veloped imaging techniques and accurate chemical tests, early 
diagnosis, precise localization of PLA and images-guided per-
cutaneous aspiration and drainage of abscess can be achieved 
easily. However, a high index of suspicion with PLA is the 
cornerstone of prevention for misdiagnosis and improvement 
for prognosis. The present study is a retrospective analysis of 47 
patients with PLA managed in a hospital of China mainland in 
the past decade. The demographic, clinical, laboratory and mi-
crobiological features, and management outcomes were studied.
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MATERIALS AND METHODS
In-patients medical records with a principal diagnosis of liver 
abscess in the Second Affiliated Hospital of Nanjing Medical 
University, Nanjing, were identified using the clinical document 
database of the hospital. From June 2000 to June 2010, all eth-
nic Chinese patients with liver abscess were identified. All were 
adult patients older than 18 years. Amoebic liver abscess and 
fungal liver abscess were excluded from the analysis. Newer 
interventional procedures, radiofrequency ablation (RFA) or 
after transcatheter arterial chemoembolization (TACE) may lead 
to PLA of hepatic tumor, and the application time of RFA and 
TACE varied from hospital to hospital in China in the recent de-
cade. Therefore, cases with RFA or TACE associated infection in 
liver cancer focus were excluded for decreasing bias. 
The following demographic data and clinical information 
were obtained from each patient’s record: age, gender, present-
ing symptoms and signs, number of non-malignant comor-
bidities, underlying etiology, diabetes mellitus, presence of 
malignancy, positive microbiological culture (including blood 
and abscess aspirate), electrocardiogram (ECG) with ST seg-
ment elevation, imaging modality performed, characteristics of 
abscess (size, location, and number of abscesses), percutaneous 
aspiration performed or not, drainage catheter inserted or not, 
duration of drainage, requirement of surgical treatment, number 
of days needed to establish diagnosis, duration of hospital stay, 
and treatment outcome. The following laboratory parameters 
were retrieved for analysis: white cell count, platelet count, 
blood levels of C-reactive protein, hemoglobin, urea, creatinine, 
albumin, globulin, total bilirubin, alkaline phosphatase (ALP), fi-
brinogen and alanine transaminase (ALT), prothrombin time (PT), 
and activated partial thromboplastin time (APTT). The value on 
the day of admission was chosen for analysis. Toxic myocarditis 
was diagnosed according to clinical presentation, ST segment 
elevation
9 and serum cardiac biomarkers (creatine kinase, tropo-
nin I and T).
10
Statistical analysis was performed using SPSS version 11.0 
(SPSS Inc., Chicago, IL, USA) software. All continuous data was 
expressed as mean±standard deviation (SD). Statistics used in-
cluded chi-squared test, Fisher’s exact test and Student’s t-test, 
Mann–Whitney U test and Wilcoxon Signed Rank Test. Differ-
ences were considered statistically significant at p<0.05.
RESULTS
1. Clinical features
From June 2000 to June 2010 inclusive, 56 patients were 
diagnosed with PLA at the Second Affiliated Hospital, Nanjing 
Medical University. Forty-seven of 56 patients with complete 
documents being available were included. All patients were 
ethnic Chinese. Twenty-five patients were men and 22 women 
(male-to-female ratio, 1.14:1). The age range was 35 to 88 years 
(mean±SD, 59.6±12 years). The age group with the greatest 
number of patients was 51 to 60 years (Fig. 1), followed by the 
second age group 41 to 50 years, instead of 61 to 70 years. As 
shown in Table 1, the most common presenting features were 
fever and chills (95.7%), followed by right upper quadrant pain 
and/or epigastric discomfort in 24 patients (51.1%). Comorbi    dity 
included hypertension, diabetes mellitus, senile stroke, ischemic 
heart disease, congestive heart failure, malignant diseases (two 
with colon cancer, another two with bile ducts cancer) and bili-
ary diseases. Twenty-four patients (51.1%) had diabetes mel-
litus. Interestingly, seventeen (36.2%) had renal cysts. Diabetes 
Fig. 1. Age distribution of 47 patients with pyogenic liver abscess.
No., number.
Table 1. Clinical Features of 47 Patients with Pyogenic Liver Abscess
Clinical features No. (%)
Fever and chills 45 (95.7)
Right upper quadrant pain/epigastric discomfort 24 (51.1)
Jaundice 17 (36.2)
Diabetes mellitus 24 (51.1)
Accompanying malignant diseases 4 (8.5)
Shock   5 (10.6)
Toxic myocarditis 2 (4.3)
Renal cyst 17 (36.2)
No., number.
Table 2. Comorbid Diseases in Patients with Pyogenic Liver Abscess
No. of comorbid diseases No. of patients (%)
0 11 (23.4)
1 11 (23.4)
2 15 (31.9)
3 8 (17)
4  1 (2.1)
5  1 (2.1)
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mellitus was associated with occurrence of infection induced 
shock when compared to non-diabetic group (p=0.049). There 
was no significant finding in any of other parameters in Table 
1 between patients with diabetes mellitus and patients without 
diabetes mellitus.
Twenty-five patients (53.2%) had two or more comorbid 
diseases (Table 2), such as cholelithiasis, cholecystitis, pneu-
monia, diabetes mellitus and cancer. Patients with two or more 
comorbid diseases had longer duration of hospitalization when 
compared to patients with one or without any comorbid disease 
(Wilcoxon Signed Rank Test, p<0.001). 
2. Laboratory features
The most common laboratory abnormality among investigat-
ed and included items was increased ALP in 38 patients (80.9%) 
(Table 3). This was followed by leukocytosis in 35 patients 
(74.5%), increased fibrinogen (73.3%, 11 of 15 investigated cas-
es) and elevated ALT in 22 patients (46.8%). Notably, infection-
induced thrombocytopenia occurred in 8 patients (17%) and 
haematuria was confirmed by urine test in 8 patients (17%). 
Interestingly, 12 patients (25.5%) had a normal white blood cell 
count and 30 patients (63.8%) had normal total bilirubin. 
3. Microbiological ﬁ  ndings
Blood or abscess culture was positive in 20 of 47 patients 
(42.6%) (Table 4). Culture from aspirate of liver abscess was 
positive in 74 of 89 patients who underwent percutaneous aspi-
ration of liver abscess (positive rate, 83.1%). The most common 
organism identified was Kle    bsiella spp. (19.1%), followed by 
Esc  herichia coli (12.8%). 
4. Radiological features
Ultrasound as most convenient and first-line investigation 
was performed for 47 patients (100.0%). Computed tomography 
(CT) scan or/  and magnetic resonance imaging (MRI) were per-
formed if they were further needed for differential diagnosis of 
liver cancer or cancer with infection and the investigation was 
done with the consent of patients. Twenty (42.6%) of 47 cases 
underwent CT scanning and 5 (10.6%) cases with MRI. The data 
of sizes of abscess were collected from the radiological reports. 
As shown in Table 5, the mean size of liver abscess was 6.7±4.0 
cm (range, 1 to 24 cm). The majority of patients had solitary 
liver abscess (85.1%). Most of the liver abscesses were found in 
the right hepatic lobe (83%). Between the group of patients with 
multiple abscesses (≥2 abscess, n=7) and patients with solitary 
liver abscess (n=40), there was no significant finding for gender, 
diabetic, symptom, white blood cell count, platelets changing 
(p>0.05) (Table 5). Between the group of patients with large 
abscesses (diameter ≥6.7 cm) and patients with small abscess 
(<6.7 cm), there was no significant finding for gender, diabetic, 
symptom, white blood cells count, platelets changing (p>0.05). 
Patients with large abscesses had longer duration of hospitaliza-
tion when compared to patients with the group of small size of 
Table 3. Laboratory Features of 47 Patients with Pyogenic Liver Ab-
scess
Lab features No. of patients (%)
ALP elevation   38 (80.9)
Leukocytosis  35 (74.5)
Fibrinogen elevation    11 (73.3% 
of 15 investigated cases)
ALT elevation  22 (46.8)
Infection-induced thrombocytopenia 8 (17)
Haematuria 8 (17)
17.1≤Total bilirubin <34.2 μmol/L  11 (23.4)
Total bilirubin ≥34.2 μmol/L    6 (12.8)
No., number.
Table 4. Microbiological Findings of 47 Patients with Pyogenic Liver 
Abscess
Bacterial culture No. of patients (%)
Blood culture only 30 (63.8)
Blood+abscess 17 (36.2)
Positive 20  (42.6)
  Klebsiella spp.   9 (19.1)
  Escherichia coli   6 (12.8)
Polymicrobial infection 2 (4.3)
  Enterococcus avium 1 (2.1)
  Enterobacter cloacae 1 (2.1)
Unidenfined polymicrobial infection  1 (2.1)
No., number.
Table 5. Radiologic Characteristics of Pyogenic Liver Abscess
Variable No. of patients (%)
Size, mean±SD (range), cm 6.7±4.0 (1-24)
No. of abscess
  1 40 (85.1)
  2 2 (4.3)
  3 2 (4.3)
  4 2 (4.3)
  5 1 (2.1)
Location of abscess
  Right lobe 39 (83.0% of 47 cases)
    Right anterior lobe   4 (10.3% of 39 cases)
    Right posterior lobe 16 (41.0% of 39 cases)
    Not described 19 (41.0% of 39 cases)
  Left lobe   7 (14.9% of 47 cases)
  Bi-lobed 1 (2.1)
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abscess (37.3±17.3 days vs. 25.0±10.8 days, p=0.01). 
5. The potential causes of the PLA
As shown in Table 6 and Fig. 2, the cause of PLA in 17 
patients (36.2%) was not clear. Benign biliary tract diseases, 
including cholelithiasis and cholecystitis were identified in 18 
patients (38.3%). The cause of PLA in 8 patients (17.0%) was 
assigned to be hematogenous origin. Endoscopic retrograde 
cholangiopancreatography (ERCP) or percutaneous transhepatic 
cholangio drainage (PTCD) leaded to PLA in two patients with 
hepato-pancreatico-biliary (HPB) (Fig. 2) malignancy and biliary 
obstruction. One patient developed liver abscess after choledo-
chojejunostomy.
6. Management and outcome
Intravenous broad spectrum antibiotics were given to all pa-
tients. The reason for not performing image-guided aspiration 
and drainage was small size of the abscess <2-3 cm, no lique-
faction in the abscess, or clinical improvement with antibiotics. 
Ultrasound or CT-guided needle aspiration of liver abscess was 
performed in 18 (38.3%) patients, 8 (17.0%) of these patients 
underwent continuous drainage after needle aspiration. The 
range of drainage duration was 3 to 14 days. Surgery or drain-
age after surgery was required in three patients (6.4%). There 
was no major complication of interventional drainages or per-
cutaneous aspiration. ERCP was not used as the interventional 
method to treat liver abscess. One patient (2.1%) died before 
percutaneous aspiration or surgery. 
Accurate diagnosis of PLA was achieved at a median duration 
Table 6. Causes of Pyogenic Liver Abscess
Associated causes No. of patients (%)
Cryptogenic 17  (36.2)
Biliary causes  18 (38.3)
  Cholelithiasis 11 (23.4)
  Cholecystitis   7 (14.9)
Hematogenous   8 (17.0)
Post-ERCP or PTCD* 2 (4.3)
Choledochojejunostomy 1 (2.1)
Dilation of common bile duct 1 (2.1)
No., number.
*Post-endoscopic retrograde cholangiopancreatography (ERCP) or 
percutaneous transhepatic cholangio drainage (PTCD) in patients with 
hepato-pancreatico-biliary cancer.
Fig. 2. Causes of pyogenic liver abscess. 
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopan-
creatography; PTCD, percutaneous transhepatic cholangio drainage; 
CJ, choledochojejunostomy.
Fig. 3. Electrocardiogram (ECG) tracking at 8 hours (A), 12 hours 
(B), and 56 hours (C) after admission in a typical case with infection-
induced toxic myocarditis. No obvious ST elevation is observed in the 
emergent ECG prior to admission (data not shown).Zhu X, et al: A Retrospective Analysis of Pyogenic Liver Abscess  225
of 3 days after admission (range, 1 to 11 days). Mean hospital 
days was 28.3 days (28.3±16.5 days; range, 2 to 68 days). Wil-
coxon Signed Rank Test showed the number of days needed to 
establish diagnosis was correlated with the number of hospital 
days (p<0.001). One patient died within the same hospital ad-
mission (mortality, 2.1%), and 5 patients (10.6%) required to be 
referred to local primary hospital for further treatment.
According the documents, the most serious condition with 
dramatically changing was the patient with final diagnosis as 
PLA associated with toxic myocarditis, shock, infection induced 
thrombocytopenia and type 2 diabetes mellitus. The patient, 
a 44-year-old man, was admitted to hospital without positive 
finding by liver ultrasound 12 hours before admission. Twenty 
hours after admission, the platelets decreased to 10×10
9/L, and 
ECG showed elevation in all ST-segments of six leads (Fig. 3) 
and also increase in cardiac-specific troponin T and troponin I 
more than 20 times the normal level. The patient had no chest 
pain and ST segments elevation further remained for 24 hours. 
Platelet transfusion was given after thrombotic thrombocyto-
penia purpura and heparin-induced thromb  ocytopenia were 
precluded. Ultrasound showed 6.0×5.0 cm size of liver abscess 
at the second day after admission. ECG and cardiac markers 
were followed up 1 to 2 times per two days in the first week (data 
not shown). After 15 days of treatment using intravenous third-
generation cephalosporins with metronidazole, the patient was 
discharged with the prescription of one week-oral ciprofloxacin.
DISCUSSION
The clinical presentation in many cases of PLA are non-spe-
cific in nature and are difficult to diagnose early.
7 This disease 
is particularly important in emergency room since the time for 
patient evaluation is often limited and mortality is high. PLA 
was traditionally considered as a subacute entity with a median 
of symptom duration before admission of over 2 weeks.
11 A 
high index of suspicion should be maintained in patients with 
diabetes mellitus, previous biliary tract intervention or gastro-
intestinal malignancy.
12 The trend of PLA varies from region to 
region
3,4,13-15 and was even called as an endemic disease.
15 How-
ever, there are very few English literatures reflecting the chang-
ing trend of PLA in China mainland.
The previous studies focusing on the period from 1990-2000
4 
and 1998-2004
3 in Hong Kong reported that there had been a 
trend for progressive increase in the age of presentation of PLA. 
The mean age of these patient in the later report
3 was 62.6 years 
and the age group with the greatest number of patients was 61 
to 70 years. However, our retrospective review from 2000-2010 
in Nanjing (in China mainland) showed the mean age was 59.6 
years, and the age group with the greatest number of patients 
was 51 to 60 years (Fig. 1), followed by the age group 41 to 50 
years, instead of group 61 to 70 years. Local economic status 
and the health care support system in China mainland before 
2005 may be one of important aspects affecting trends chang-
ing, including the timely and effective treatment on biliary 
diseases, the hematogenous spread from distant foci, diabetes 
mellitus and so on.
Newer interventional procedures such as RFA or TACE lead-
ing to PLA of hepatic tumor
16-18 and the application time of RFA 
and TACE varied from hospital to hospital in China. Therefore, 
for decreasing bias, we excluded the cases with RFA or TACE 
associated infection in liver cancer focus. 
The presenting features can be non-specific and the diagnosis 
requires a high index of suspicion. It is interesting to note that 
right upper quadrant pain/epigastric discomfort was present in 
51.1% of patients. Twelve patients (25.9%) had normal white 
blood cell count. Diabetes mellitus is also commonly found,
13 
reflecting the importance of host immunity in the pathogenesis 
of this condition. The present results indicated that diabetes 
mellitus may be associated with occurrence of infection induced 
shock. Cryptogenic PLA was the most frequently noticed and 
was followed by benign biliary tract diseases, as the most fre-
quently identifiable cause in 18 patients (38.3%). The abscess 
was most common in right lobe (83%). Previous studies
3,4,19 also 
reported similar findings. 17.0% of PLA were hematogenous 
spread from distant foci in gastrointestinal tract, urinary tract 
and even foreign body.
20 Patients with two or more comorbid 
diseases may be prior to patients with one or without any co-
morbid disease have longer duration of hospitalization. 
The laboratory features are also non-specific for diagnosis 
of PLA. Notably, the ratio of leukocytosis in 47 patients (35, 
74.5%) was followed by increased fibrinogen (73.3%, 11 of 15 
investigated cases), indicating fibrinogen may be a promising 
circulation marker for infection, at least as a useful early marker 
for PLA. Further studies based on large samples are needed. 
Similarly, the most frequent organism isolated from blood 
and abscess aspirate was Enterobacteriaceae (Klebsiella   spp., fol-
lowed by Escherichia coli).
4,21 This is probably explained by the 
high incidence of a biliary cause of liver abscess.
1-4,11,19,22,23 The 
low positive rate of bacterial culture (44/80, 55%) was probably 
related to the use of empirical antibiotics treatment prior to the 
drainage procedure. 
Intravenous antibiotics were given to all these patients and 
this was the only treatment for 22 patients (19.8%). The most 
commonly used antibiotics were second and third-generation 
cephalosporins with or without metronidazole. This regimen 
covered most of the identified organisms and was similar to 
regimens used in other centers.
3,4 Based on the classic work, 
open surgical drainage or closed aspiration, ultrasound or CT-
guided needle aspiration of liver abscess was performed in 18 
(38.3%) patients, 8 (17.0%) of these patients underwent continu-
ous drainage. The range of drainage duration was 3 to 14 days. 
Surgery or drainage after surgery was required in three patients 
(6.4%). The application rate of interventional treatment is much 
lower than that in the previous report
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ration of liver abscess was performed in 80.2% of patients and 
catheters were inserted in 68.5% of patients in a Hong Kong 
hospital.
Ultrasound was reported as 85.8% sensitivity of liver abscess 
at emergency department.
12 In the present study, one patient’s 
condition (briefly introduced in Results) deteriorated dramati-
cally even he had no positive ultrasound finding when he had 
shock, infection induced thrombocytopenia and serious toxic 
myocarditis. Patients with such non-specific clinical features 
could pose a diagnostic challenge to clinicians. Effective intra-
venous antibiotics and systemic treatments (without interven-
tional procedures) at early stage showed the importance to short 
the hospital days. 
ERCP has been found to be a useful investigation and treat-
ment modality for patients with PLA.
3,4,23,24 These reports high-
lighted that ERCP is useful in the treatment of patients with 
PLA. However, in this series, there was no patient who under-
went ERCP for treating PLA. Interestingly, in the two patients 
with biliary malignancy and common bile duct obstruction PLA 
occurred after they underwent ERCP or PTCD, respectively. This 
indicates that biliary interventional therapy may be the cause 
leading to or increasing the possibility of PLA.
A previous study reflected that age, rupture at presentation, 
emergency laparotomy, malignancy, hyperbilirubinemia, and 
elevated prothrombin time were risk factors associated with 
in-hospital mortality during period from 1984-1995 in Hong 
Kong.
25 In another Hong Kong’s study
3 from 1998-2004, authors 
showed that malignancy, requirement for surgical intervention, 
and delayed diagnosis were independent risk factors associated 
with in-hospital mortality. Malignancy has long been described 
as a poor prognostic factor for patients with PLA.
3,4,19,23,25,26 Poor 
nutritional status and an immunocomprised state are the likely 
factors contributing to the poor outcome.
4 In the present study 
from 2000-2010, one patient died during his hospital admission 
(mortality, 2.1%). There had n  ot been a rising trend in mortality 
with an increasing age at present,   comparing the previous re-
ports from Taiwan and Hong Kong.
1,3,4,12,15,21 The present analysis 
showed that the number of days needed to establish diagnosis 
was correlated with the number of hospital days, indicating 
early diagnosis at the early stage of PLA progression would im-
prove the prognosis and treatment outcome.
Some limitations of this study should be noted. The data 
collected may be affected by factors such as poor standard of 
record keeping and lack of proper documentation of important 
events, and can be subject to inter and/or intra-observer bias 
during case review.
3 The results represent the experience based 
on a small sample from a single center, and may not be gener-
alizable to other areas with different epidemiologic or clinical 
settings.
In conclusion, PLA are non-specific in nature and continue to 
experience significant morbidity and mortality. The number of 
days needed to establish diagnosis was correlated with the num-
ber of hospital days. The hospital day of patients with PLA can 
be further improved by early diagnosis and effective treatments 
at the early stage of PLA progression.
ACKNOWLEDGEMENTS
The work was partially supported by grants from the National 
Natural Science Foundation of China (No. 30900667) and the 
Science and Technology Foundation of Medical University 
(08NMUZ021). 
Conflicts of interest statement: None declared.
REFERENCES
1.  Yu SC, Ho SS, Lau WY, et al. Treatment of pyogenic liver abscess: 
prospective randomized comparison of catheter drainage and 
needle aspiration. Hepatology 2004;39:932-938.
2.  Alvarez Pérez JA, González JJ, Baldonedo RF, et al. Clinical 
course, treatment, and multivariate analysis of risk factors for 
pyogenic liver abscess. Am J Surg 2001;181:177-186.
3.  Lok KH, Li KF, Li KK, Szeto ML. Pyogenic liver abscess: clini-
cal profile, microbiological characteristics, and management in a 
Hong Kong hospital. J Microbiol Immunol Infect 2008;41:483-
490.
4.  Wong WM, Wong BC, Hui CK, et al. Pyogenic liver abscess: ret-
rospective analysis of 80 cases over a 10-year period. J Gastroen-
terol Hepatol 2002;17:1001-1007.
5.  Miedema BW, Dineen P. The diagnosis and treatment of pyogenic 
liver abscesses. Ann Surg 1984;200:328-335.
6.  Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. 
Changing trends over 42 years. Ann Surg 1996;223:600-607.
7.  Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. In-
fect Dis Clin North Am 2000;14:547-563, vii.
8.  Halvorsen RA Jr, Foster WL Jr, Wilkinson RH Jr, Silverman PM, 
Thompson WM. Hepatic abscess: sensitivity of imaging tests and 
clinical findings. Gastrointest Radiol 1988;13:135-141.
9.  Wang K, Asinger RW, Marriott HJ. ST-segment elevation in 
conditions other than acute myocardial infarction. N Engl J Med 
2003;349:2128-2135.
10.  Magnani JW, Dec GW. Myocarditis: current trends in diagnosis 
and treatment. Circulation 2006;113:876-890.
11.  Bamberger DM. Outcome of medical treatment of bacterial ab-
scesses without therapeutic drainage: review of cases reported in 
the literature. Clin Infect Dis 1996;23:592-603.
12.  Lin AC, Yeh DY, Hsu YH, et al. Diagnosis of pyogenic liver abscess 
by abdominal ultrasonography in the emergency department. 
Emerg Med J 2009;26:273-275.
13. Kurtz LE, Greenberg RE. Pyogenic liver abscess associated with a 
gastrointestinal stromal tumor of the stomach. Am J Gastroenterol 
2010;105:232-233.
14.  Shah I, Bhatnagar S. Liver abscess in a newborn leading to portal 
vein thrombosis. Indian J Pediatr 2009;76:1268-1269.Zhu X, et al: A Retrospective Analysis of Pyogenic Liver Abscess  227
15.  Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as 
endemic disease, Taiwan. Emerg Infect Dis 2008;14:1592-1600.
16.  Cheung YC, Ko SF, Ng SH, Chan SC, Cheng YF. Survival outcome 
of lobar or segmental transcatheter arterial embolization with eth-
anol-lipiodol mixture in treating hepatocellular carcinoma. World 
J Gastroenterol 2005;11:2792-2795.
17.  Hanazaki K, Kajikawa S, Horigome N, et al. Gas-forming liver 
abscess after transcatheter arterial embolization for hepatocellular 
carcinoma: report of a case. Surg Today 1993;23:747-749.
18. Hashimoto T, Mitani T, Nakamura H, et al. Fatal septic complica-
tion of transcatheter chemoembolization for hepatocellular carci-
noma. Cardiovasc Intervent Radiol 1993;16:325-327.
19.  Foo NP, Chen KT, Lin HJ, Guo HR. Characteristics of pyogenic 
liver abscess patients with and without diabetes mellitus. Am J 
Gastroenterol 2010;105:328-335.
20. Santos SA, Alberto SC, Cruz E, et al. Hepatic abscess induced by 
foreign body: case report and literature review. World J Gastroen-
terol 2007;13:1466-1470.
21.  Lee SS, Chen YS, Tsai HC, et al. Predictors of septic metastatic in-
fection and mortality among patients with Klebsiella pneumoniae 
liver abscess. Clin Infect Dis 2008;47:642-650.
22.  Arakura N, Ozaki Y, Yamazaki S, et al. Abscess of the round liga-
ment of the liver associated with acute obstructive cholangitis and 
septic thrombosis. Intern Med 2009;48:1885-1888.
23. Lam YH, Wong SK, Lee DW, et al. ERCP and pyogenic liver ab-
scess. Gastrointest Endosc 1999;50:340-344.
24.  Dull JS, Topa L, Balgha V, Pap A. Non-surgical treatment of bili-
ary liver abscesses: efficacy of endoscopic drainage and local 
antibiotic lavage with nasobiliary catheter. Gastrointest Endosc 
2000;51:55-59.
25.  Chu KM, Fan ST, Lai EC, Lo CM, Wong J. Pyogenic liver ab-
scess. An audit of experience over the past decade. Arch Surg 
1996;131:148-152.
26. Chong VH, Lim KS. Pyogenic liver abscess as the first manifesta-
tion of hepatobiliary malignancy. Hepatobiliary Pancreat Dis Int 
2009;8:547-550.